دورية أكاديمية
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study
| العنوان: | Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study |
|---|---|
| المؤلفون: | McAllister, Peter, Winner, Paul K.Aff2, Aff3, Aff4, Aff5, Aff6, Ailani, Jessica, Buse, Dawn C.Aff8, Aff9, Lipton, Richard B., Chakhava, George, Josiassen, Mette Krog, Lindsten, Annika, Mehta, Lahar, Ettrup, Anders, Cady, RogerAff13, IDs10194021013767_cor11 |
| المصدر: | The Journal of Headache and Pain: Official Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache". 23(1) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 11292369 11292377 |
|---|---|
| DOI: | 10.1186/s10194-021-01376-7 |